Psychedelics: The Microdosing Phenomenon
Psychedelics are experiencing a resurgence in the 21st century, making the term “psychedelic renaissance” an apt descriptor for the movement. Author and journalist Michael Pollan aptly captures the sentiment, describing this time as the most exciting and bewildering in the world of psychedelics. From medicine and therapy to self-improvement and spiritual transformation, psychedelics are making their mark in various domains of modern society.
Finding Renewed Traction
The recent Psychedelic Science 2023 conference, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), showcased the growing interest in psychedelics. With 12,000 attendees, the conference boasted presentations from pioneers in the field like Rick Doblin, the founder of MAPS, and surprising participants like Rick Perry, the former Governor of Texas with a right-wing Republican background.
Despite some setbacks, such as the fallout from sexual misconduct allegations against research therapists affiliated with MAPS, psychedelics are gaining acceptance and endorsement from both the general public and institutions. The usage of hallucinogens among young adults in the US has increased from 3% in 2011 to 8% in 2021. Governments and industry, including venture capital firms, are investing billions in psychedelics research and development, with burgeoning interest in their potential as therapies and pharmaceuticals.
The Emergence of Microdosing
Within the psychedelic landscape, a vibrant subculture centered around microdosing has emerged. Microdosing involves consuming small amounts of psychedelic substances on a regular basis for an extended period. While much attention and funding have focused on clinical trials and standard doses for treating mental health problems, microdosing has primarily remained exploratory and observational, lacking rigorous scientific studies.
Microdosers benefit from perceived enhancements in cognitive and intellectual performance, as well as improvements in mood, anxiety reduction, and increased focus and creativity. Some microdosers have likened the effects to stimulants for ADHD or SSRIs for depression. The practice has even caught the attention of the US Marines, who are exploring microdosing as a means to boost productivity, creativity, problem-solving, and flow.
Evidence and Expectations
From an evidence-based perspective, the scientific understanding of microdosing is still in its infancy. Some studies suggest that the reported benefits may be attributed to the placebo effect, where the expectation of improvement influences the outcome. However, the consistently positive and persuasive anecdotal accounts have driven scientists to delve further into understanding the practice.
In the psychedelic community, microdosing has its own distinctive definition, typically involving 5-10% of a standard or “trippy” dose. Individuals who microdose seek to derive the psychological and cognitive benefits of psychedelics without experiencing the characteristic hallucinations and intense psychological transformations associated with higher doses. While the scientific literature on microdosing is limited, studies have shown mixed results in areas such as depression, anxiety, creativity, and cognitive function.
Assessing Risks and Benefits
Before considering microdosing, individuals should conduct a physical and mental health assessment to evaluate the potential benefits and risks. Psychologically, microdosing should be approached with caution, as psychedelic substances can trigger a range of perceptual effects and may exacerbate pre-existing mental health conditions. Cardiovascular risks associated with prolonged exposure to psychedelics are also a concern.
Choosing the right substance for microdosing is crucial. LSD and magic mushrooms are the most commonly microdosed psychedelics due to their safety profile and availability. Precise measurement and storage of microdoses are key to ensuring a consistent experience and maintaining the potency of the substances.
Anecdotes vs. Science
Anecdotal reports of microdosing often highlight profound personal transformations and improvements in various aspects of life. While these accounts should be considered, they cannot be taken as definitive proof due to the influence of expectancy and placebo effects, as well as the lack of rigorous scientific studies.
Despite the inconclusive evidence, microdosing continues to attract individuals seeking cognitive enhancements and personal growth. However, caution should be exercised, considering the potential risks, individual variability in response, and lack of scientific consensus on optimal dosing protocols.
In conclusion, microdosing offers a unique avenue for individuals to explore the potential benefits of psychedelics without the intensity associated with high doses. While the scientific literature on microdosing is still growing, anecdotal accounts highlight potential cognitive and psychological improvements. The key is to approach microdosing with caution, attentiveness, and a thorough understanding of personal health factors.
